CRISPR and crRNAs
CRISPR
Hybridoma Technology
Health Information Technology and Healthcare Information System
Frustration and Conflict: Approach-Approach, Approach-Avoidance
The Antiviral System of Bacteria and Archaea: CRISPR
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 26, 2026

Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
Petros Patsali1, Marina Kleanthous1,2, Carsten W Lederer3,4
1Department of Molecular Genetics Thalassaemia, The Cyprus Institute of Neurology and Genetics, 6 International Airport Avenue, 1683, Nicosia, Cyprus.
CRISPR-Cas technology offers powerful genome editing tools for therapy, with ongoing development expanding their capabilities. However, improving efficiency and addressing safety concerns like off-target effects are crucial for therapeutic applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: